Inhibition of human platelet aggregation by diazeniumdiolates: Extent of inhibition correlates with nitric oxide load delivered

被引:9
|
作者
Raulli, R [1 ]
机构
[1] Amer Red Cross, Jerome H Holland Lab, Cell Biol Lab, Rockville, MD 20853 USA
关键词
D O I
10.1111/j.2042-7158.1998.tb03308.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The profile of nitric oxide (NO) release from the diazeniumdiolate class of NO donors was evaluated using inhibition of platelet aggregation as a model. At 37 degrees C, the NO complexes (Z)-1-{N-methyl-N-[6-(N-methylammoniohexyl)amino]}-diazen-1-ium-1,2-diolate (dimethylhexanediamine complex), sodium (Z)-1-(N,N-diethylamino)diazen-1-ium-1,2-diolate (diethylamine complex), (Z)-1-{N-[3-aminopropyl]-N-[4-(3-aminopropylammonio)butyl]amino}diazeb-1-ium-1,2-diolate (spermine complex), and (Z)-1-[N-(2-aminoethyl)-N-(2-ammonioethyl)amino]diazen-1-ium-1,2-diolate (diethylene-triamine complex) have half-lives of 1, 2 and 39 min, and 20 h, respectively. All the diazeniumdiolates caused concentration-dependent inhibition of platelet aggregation; IC50 values (values for which the effect was half the maximum) were 26.0+/-24.1, 34.9+/-24.0 and 14.9+/-6.4 nM for dimethylhexanediamine complex, diethylamine complex and spermine complex, respectively, when pre-incubated with platelets for one half-life. Inhibition by all compounds was time-dependent. Pretreatment of platelets with spermine complex for 5 and 39 min resulted in IC50 values of 1.7+/-0.85 mu M and 19.7+/-0.12 nM, whereas IC50 values for sodium nitroprusside were 27.3+/-1.25 nM and 25 nM (average, n = 2), at 5 and 39 min, respectively. Pre-incubation of each diazeniumdiolate at a concentration of 100 nM for 5 min at 37 degrees C, which resulted in the theoretical delivery of NO loads from 96.9% down to 0.3%, resulted in decreasingly efficacious inhibition of platelet aggregation. Linear regression analysis of the theoretical NO load delivered against the actual maximum inhibition (%) showed a strong correlation (r(2) = 0.975). All four diazeniumdiolates caused concentration-and time-dependent inhibition of agonist-stimulated elevation of intra-platelet Ca2+ levels; IC50 values were, respectively, 8.7+/-1.49 nM and 11.5+/-1.36 nM for dimethylhexanediamine complex and diethylamine complex at their half-lives, and 176+/-16.9 nM and > 100 mu M, for spermine complex and diethylenetriamine complex at 2 min pre-incubation time. The respective nucleophiles not complexed with NO did not show anti-aggregatory properties or inhibition of agonist-induced elevation of intraplatelet Ca2+ levels. The inhibitory effects of all diazeniumdiolates tested were attenuated by 10 mu M haemoglobin. These studies indicate that these compounds induce controlled, predictable release of NO at biological pH and temperature.
引用
收藏
页码:75 / 82
页数:8
相关论文
共 50 条
  • [31] DIPYRIDAMOLE POTENTIATES PLATELET INHIBITION BY NITRIC-OXIDE
    BULT, H
    FRET, HRL
    JORDAENS, FH
    HERMAN, AG
    THROMBOSIS AND HAEMOSTASIS, 1991, 66 (03) : 343 - 349
  • [32] Rapid reversibility of nitric oxide induced platelet inhibition
    Brüne, B
    Hanstein, K
    THROMBOSIS RESEARCH, 1998, 90 (02) : 83 - 91
  • [33] Nitric oxide and platelet aggregation
    Riddell, DR
    Owen, JS
    VITAMINS AND HORMONES - ADVANCES IN RESEARCH AND APPLICATIONS, VOL 57, 1999, 57 : 25 - 48
  • [34] A potential role for extracellular nitric oxide generation in cGMP-independent inhibition of human platelet aggregation: biochemical and pharmacological considerations
    Crane, MS
    Rossi, AG
    Megson, IL
    BRITISH JOURNAL OF PHARMACOLOGY, 2005, 144 (06) : 849 - 859
  • [35] INHIBITION OF HUMAN PLATELET-AGGREGATION BY PHOSPHOLIPASE-A
    IATRIDIS, SG
    IATRIDIS, PG
    MARKIDOU, SG
    RAGATZ, BH
    THROMBOSIS RESEARCH, 1976, 9 (04) : 335 - 344
  • [36] INHIBITION OF HUMAN-PLATELET AGGREGATION BY PHENYLHYDRAZINE AND ACETYLPHENYLHYDRAZINE
    LEIPZIG, RM
    WEKSLER, BB
    DRAYER, DE
    REIDENBERG, MM
    CLINICAL RESEARCH, 1984, 32 (02): : A243 - A243
  • [37] INHIBITION OF PLATELET-AGGREGATION BY HUMAN-PLACENTA
    DEMBELEDUCHESNE, MJ
    LAHLOU, AL
    THALERDAO, H
    DEPAULET, AC
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (02) : 431 - 437
  • [38] INHIBITION OF PLATELET-AGGREGATION BY HUMAN-PLASMA
    SAEED, SA
    BADI, G
    KARIMI, SJ
    SURIA, A
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1986, 14 (06) : 1295 - 1296
  • [39] NITRIC-OXIDE SYNTHASE INHIBITION AND PLATELET-FUNCTION
    BODZENTALUKASZYK, A
    GABRYELEWICZ, A
    LUKASZYK, A
    BIELAWIEC, M
    KONTUREK, JW
    DOMSCHKE, W
    THROMBOSIS RESEARCH, 1994, 75 (06) : 667 - 672
  • [40] Nitric oxide inhibition of platelet activation during cardiopulmonary bypass
    Prager, MD
    Eberhart, RC
    Jessen, M
    Sly, MK
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 358 - 358